Dr. Steven M. Powell

Gastroenterology
1215 Lee St, 
Charlottesville, VA 
Accepting New Patients
Offers Telehealth
1215 Lee St, 
Charlottesville, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Powell is a Gastroenterologist in Charlottesville, Virginia. Dr. Powell is rated as an Experienced provider by MediFind in the treatment of Collagenous Colitis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Familial Adenomatous Polyposis, DICER1 Syndrome, Endoscopy, and Colonoscopy. Dr. Powell is currently accepting new patients.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in VA
Hospital Affiliations
University Of Virginia Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

UNIVERSITY OF VIRGINIA PHYSICIANS GROUP
1215 Lee St, Charlottesville, VA 22908

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Carboplatin, Cetuximab
Study Phase: Phase 2
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
Validation of a Novel Clinical Prediction Scoring System for Improved Bowel Preparation Prior to Outpatient Colonoscopy
Validation of a Novel Clinical Prediction Scoring System for Improved Bowel Preparation Prior to Outpatient Colonoscopy
Enrollment Status: Withdrawn
Publish Date: December 12, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: SGN-CD228A
Study Phase: Phase 1
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: September 21, 2022
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy, Pembrolizumab Immunotherapy, Dexamethasone
Study Phase: Phase 2
Phase 1 Trial of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta (VSV-IFNβ-NIS) Monotherapy and in Combination With Avelumab, in Patients With Refractory Solid Tumors
Phase 1 Trial of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon Beta (VSV-IFNβ-NIS) Monotherapy and in Combination With Avelumab, in Patients With Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: April 27, 2022
Intervention Type: Biological
Study Phase: Phase 1
View 5 Less Clinical Trials

15 Total Publications

Association between dietary fructose and human colon DNA methylation: implication for racial disparities in colorectal cancer risk using a cross-sectional study.
Association between dietary fructose and human colon DNA methylation: implication for racial disparities in colorectal cancer risk using a cross-sectional study.
Journal: The American journal of clinical nutrition
Published: March 25, 2024
Similar Doctors
Distinguished in Collagenous Colitis
Dr. Dennis Kumral
Gastroenterology
Distinguished in Collagenous Colitis
Dr. Dennis Kumral
Gastroenterology

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
Languages Spoken:
English, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Dennis Kumral is a Gastroenterologist in Charlottesville, Virginia. Dr. Kumral is rated as an Advanced provider by MediFind in the treatment of Collagenous Colitis. His top areas of expertise are Celiac Disease, Collagenous Colitis, Colitis, Colonoscopy, and Endoscopy. Dr. Kumral is currently accepting new patients.

Advanced in Collagenous Colitis
Dr. Renick Smith
Gastroenterology
Advanced in Collagenous Colitis
Dr. Renick Smith
Gastroenterology

Richmond Multi-Specialty LLC

1451 Hospital Dr, Suite 201, 
Fredericksburg, VA 
 (58.1 miles away)
540-361-2040
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Renick Smith is a Gastroenterologist in Fredericksburg, Virginia. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Collagenous Colitis. His top areas of expertise are Heartburn, Diverticular Disease, Familial Adenomatous Polyposis, Gastrectomy, and Endoscopy.

Advanced in Collagenous Colitis
Dr. Andrew Copland
Gastroenterology
Advanced in Collagenous Colitis
Dr. Andrew Copland
Gastroenterology

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Copland is a Gastroenterologist in Charlottesville, Virginia. Dr. Copland is rated as a Distinguished provider by MediFind in the treatment of Collagenous Colitis. His top areas of expertise are Crohn's Disease, Colorectal Cancer, Diarrhea, Endoscopy, and Colonoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Powell's expertise for a condition
ConditionClose
      View All 16 Advanced Conditions
      View All 59 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile